SEP 30, 2024·BEHAVIORAL HEALTH BUSINESSNEWS
‘Setting a Precedent’: Cognoa Earns Medicaid Coverage for Early-Autism Diagnosis Tool - Behavioral Health Business§01 · Overview
About Cognoa.
FDA-authorized AI-powered autism diagnostic and developmental monitoring platform.
What they do
ASSESS
Assessment Tools
Assessment Tools
FUNCTI
Functional Behavior Assessments
Assessment Tools
INTAKE
Intake Assessments
Assessment Tools
OUTCOM
Outcome Measures
Assessment Tools
SKILLS
Skills Assessments
Assessment Tools
Product details
- Pricing notes
- Cognoa's Canvas Dx is an FDA-cleared Software as a Medical Device (SaMD) for autism diagnosis. It is prescribed by providers and covered by insurers (e.g., Highmark, Wyoming Medicaid). No public list pricing found on cognoa.com; costs are billed through insurance/payer contracts.
- Deployment
- Cloud
- Free tier
- No
§06 · Reviews
No published reviews yet.
Every reviewer's identity and engagement are verified by work-email cross-check before publication. Reviews cannot be edited or removed by the firm.
No reviews have been published for Cognoa yet. Be the first to review →
§07 · Verification
What we checked.
What we couldn't.
Every check is dated and re-runnable. If you can't reproduce the result with the source we cite, file a correction.
Verified Client Reviews
0
Overall Review Rating
—
Last Updated
—
OWNR
Ownership claim
No representative has claimed this profile yet.
PENDINGSITE
Website on file
https://www.cognoa.com
VERIFIED§09 · News
What the press is saying.
Third-party coverage of Cognoa, automatically discovered and filtered for relevance. We don't edit it. Click through to read the source.
SEP 27, 2024·MEDICAL DEVICE NETWORKNEWS
Cognoa’s AI child autism diagnostic gains Medicaid coverage in Wyoming - Medical Device NetworkJAN 26, 2024·FIERCE HEALTHCARENEWS
Cognoa's FDA-approved autism diagnostic tool now in network for Highmark members - Fierce HealthcareDEC 2, 2023·MEDICAL DEVICE AND DIAGNOSTIC INDUSTRYNEWS
Cognoa Makes Push to Get FDA Nod for Digital Autism Diagnostic - Medical Device and Diagnostic industryJUN 3, 2021·MEDTECH DIVENEWS
Cognoa’s machine learning software for autism diagnosis gets FDA nod - MedTech DiveJUN 3, 2021·MEDICAL DEVICE NETWORKNEWS
Cognoa’s AI-based autism diagnosis aid gets FDA de novo clearance - Medical Device NetworkJUN 2, 2021·FIERCE BIOTECHNEWS
Cognoa's AI app for diagnosing childhood autism gets FDA green light - Fierce BiotechAPR 6, 2021·BEHAVIORAL HEALTH BUSINESSNEWS
How Cognoa Aims to Revolutionize the Autism Diagnosis Process - Behavioral Health BusinessSEP 23, 2020·UNITE.AINEWS
Cognoa Seeks FDA Clearance for Digital Autism Diagnostic Device After Successful Study - Unite.AISEP 23, 2020·FIERCE BIOTECHNEWS
Cognoa's AI-powered diagnostic app for autism clears clinical study, heads for FDA review - Fierce Biotech§08 · Contact
Reach out to Cognoa.
Inquiries route directly to the firm. ABA Rank does not broker introductions, take referral fees, or sell inquiry data.
UnclaimedIf you work at Cognoa, you can claim this profile.Claim profile →
Cognoa hasn't claimed this profile yet. Use the website link to reach them directly.